Curcumin: New Use for an Old Spice?

Slideshow

Although recent reviews caution against overenthusiasm, what if a simple, inexpensive, and extremely low-risk anti-inflammatory was at hand?

View the information in PDF format.

Related Videos
Experts on MDD.
Experts on MDD.
Related Content

The Week in Review: September 25-29

September 30th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

Non-Psychiatric Medications With Potential to Worsen Symptoms in Major Depression

September 25th 2023

The Week in Review: September 25-29

September 30th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

Non-Psychiatric Medications With Potential to Worsen Symptoms in Major Depression

September 25th 2023

The Week in Review: September 25-29

September 30th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

Non-Psychiatric Medications With Potential to Worsen Symptoms in Major Depression

September 25th 2023
© 2023 MJH Life Sciences

All rights reserved.